Back to Careers

CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery

Back to Careers

Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health

Back to Careers

Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”

Back to Careers

CEO Dr. Hanadie Yousef discusses how the success of GLP-1/GIP receptor agonists is reshaping the treatment of chronic metabolic diseases and driving the next wave of therapeutics targeting the biology of aging at BIO 2025 in Boston

Back to Careers

CEO Dr. Hanadie Yousef joins a panel of industry leaders at BIO 2025 to explore how emerging therapeutic categories are reshaping dealmaking strategies, investment trends, and positioning in today’s evolving biotech landscape

Back to Careers

Director of Translational Biology and Pharmacology, Priya Handa, PhD, and Senior Director of Discovery and Platform, Thach Mai, showcased our research at the 23rd Biopharma Drug Discovery Nexus Conference in San Francisco

Back to Careers

CEO Dr. Hanadie Yousef shares insights on a panel, “Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines,” at SynBioBeta – The Global Synthetic Biology Conference in San Jose

Back to Careers

CEO Dr. Hanadie Yousef shares an Industry Update on JUV-161 and our plans to initiate Phase 1 studies this year at the 2025 International MDF Conference in  Indianapolis

Back to Careers

Our Senior Director of Discovery and Platform, Dr. Thach Mai, attended Google Cloud Next ‘25 to explore cutting-edge AI and cloud innovations transforming drug discovery and precision therapeutics

Back to Careers

Dr. Hanadie Yousef gave a talk on “Building a Pipeline with Purpose: Turning a Platform into Strategic Asset Value” as an invited speaker at Fierce Pharma Engage BD&L Summit in San Diego